Who signed the Avalon Globocare 8-K related to compensation changes?

The report was signed on behalf of Avalon Globocare Corp. by Luisa Ingargiola, the company’s Chief Financial Officer. Her signature appears as the authorized officer executing the filing, consistent with her senior financial leadership role at the company.

Avalon Globocare updates CFO and director pay

Q: What executive compensation changes did Avalon Globocare (ALBT) disclose?

Avalon Globocare disclosed a $175,000 bonus for its Chief Financial Officer, Luisa Ingargiola, and an increase in annual fees for lead director Steven Saunders to $95,000. These changes reward 2025 contributions and adjust compensation for ongoing board leadership responsibilities.

Q: Why did Avalon Globocare’s CFO receive a $175,000 bonus?

The Board approved a $175,000 bonus for CFO Luisa Ingargiola in consideration of her efforts in advancing Avalon Globocare’s business and financial position during the 2025 fiscal year. The payment recognizes her contributions rather than signaling new strategic actions or transactions.

Q: Does Avalon Globocare’s 8-K include new financial results or earnings data?

This 8-K focuses on compensation decisions for the CFO and lead director and does not present revenue, earnings, or detailed financial results. It describes bonus and fee approvals, not a broader update on the company’s operating performance or quarterly financial metrics.

Avalon Globocare Corp. reported changes to executive and board compensation.

Accepted by SEC EDGAR 03/10/2026 - 05:00 PM EDT

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

8-K

Rhea-AI Filing Summary

Avalon Globocare Corp. reported changes to executive and board compensation. On March 4, 2026, the Board approved a cash bonus of $175,000 for Chief Financial Officer Luisa Ingargiola in recognition of her efforts advancing the business and financial position during the 2025 fiscal year.

The Board also increased annual fees payable to lead director Steven Saunders to $95,000 for his service on the Board of Directors. These actions reflect compensation decisions rather than operational or financial performance metrics.

8-K Event Classification

2 items: 5.02, 9.01

2 items

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What executive compensation changes did Avalon Globocare (ALBT) disclose?

Avalon Globocare disclosed a $175,000 bonus for its Chief Financial Officer, Luisa Ingargiola, and an increase in annual fees for lead director Steven Saunders to $95,000. These changes reward 2025 contributions and adjust compensation for ongoing board leadership responsibilities.

Why did Avalon Globocare’s CFO receive a $175,000 bonus?

The Board approved a $175,000 bonus for CFO Luisa Ingargiola in consideration of her efforts in advancing Avalon Globocare’s business and financial position during the 2025 fiscal year. The payment recognizes her contributions rather than signaling new strategic actions or transactions.

How much will Avalon Globocare pay its lead director annually?

Avalon Globocare’s Board increased the fees payable to lead director Steven Saunders to $95,000 per year. This annual amount compensates him for his ongoing service as lead director on the Board of Directors, reflecting the responsibilities of that governance role.

Does Avalon Globocare’s 8-K include new financial results or earnings data?

This 8-K focuses on compensation decisions for the CFO and lead director and does not present revenue, earnings, or detailed financial results. It describes bonus and fee approvals, not a broader update on the company’s operating performance or quarterly financial metrics.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): March 4, 2026

AVALON GLOBOCARE CORP.

(Exact name of registrant as specified in its charter)

Delaware	001-38728	47-1685128
(State or other jurisdiction	(Commission File Number)	(IRS Employer
of incorporation)		Identification Number)

4400 Route 9 South, Suite 3100, Freehold, NJ 07728

(Address of principal executive offices, including zip code)

(732) 780-4400

(Registrant’s telephone number, including area code)

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, par value $0.0001 per share		ALBT		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 4, 2026, the Board of Directors of Avalon Globocare Corp. (the “Company”) approved the payment of a bonus in the amount of $175,000 to Luisa Ingargiola, the Chief Financial Officer of the Company, in consideration for her efforts in connection with advancing the business of the Company and its financial position during the 2025 fiscal year.

In addition, the Board of Directors also approved an increase in the fees payable to Steven Saunders to $95,000 per annum in consideration for his service as lead director of the Board

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit		Description
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

-1-

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	AVALON GLOBOCARE CORP.

Dated: March 10, 2026	By:	/s/ Luisa Ingargiola
	Name:	Luisa Ingargiola
	Title:	Chief Financial Officer

-2-

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

3 documents